FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial
| Image |  |
|---|---|
| Description | scientific article published on 23 May 2019 |
| Author/s |
author: Florence Castan Sophie Gourgou Anne Cayre Christelle de la Fouchardière Julien Taieb Pierre Laurent-Puig |
| Publication date | May 23, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |